Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Prospective Multicenter Validation Study Investigating the Possibility of Replacing Cystoscopies With High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer (UROSCOUT-1)

NCT06310759 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT06310759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06310759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Prospective Multicenter Validation Study Investigating the Possibility of Replacing Cystoscopies With High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer (UROSCOUT-1)
Lead sponsor
Tampere University Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 8, 2024
Completion date
December 31, 2029
Enrollment
3,000 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

urothelial carcinoma